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No. of assays Source of cells differential hypotonic lysis with 0.87 % w{v ammonium chloride. Erythrocyte plasma membrane transport of amino-acids was determined using the method of Winter and Christensen (1964) with l4C_ labelled amino-acids. Activity of the branched-chain amino-acid transaminases was estimated in erythrocytes and plasma, using 14C-leucine as substrate as in the method of Ichihara and Koyama (1966) modified by paper chromatographic separation for the estimation of substrate conversion. Plasma amino-acids were estimated by column chromatography (Cockburn et al., 197] ).
METHODS
Accumulation of the branched-chain amino-acids valine, leucine, and isoleucine in the blood of infants with maple syrup urine disease (MSUD) has so far been associated with defects in the oxidative decarboxylation of branched-chain o-keto acids by a mitochondrial enzyme complex (Goedde and Langenbeck, 1973) . Evidence is presented of normal oxidative decarboxylation of the branched-chain amino-acids in a child with severe MSUD. A previous, second, child in the affected family had died at 12 days of age with ketosis and the characteristic urinary amino-acid pattern of MSUD. Necropsy findings were consistent with the diagnosis, but enzymological diagnosis was not possible with the material available at this time. It was therefore necessary to assume the existence of the accepted defect of the enzyme complex when antenatal diagnosis was requested and attempted in a subsequent pregnancy. However, this assumption was proved wrong when another affected child was born with normal oxidative decarboxylation of the branched-chain amino-acids.
In view of the normal enzymic activity other points at which the three branched-chain aminoacids may be transported or metabolised together were investigated. Plasma membrane transport of leucine and valine (cf. Piperno and Oxender, 1966) by the affected child's erythrocytes was studied and found to be normal. There was also no evidence of deficiency of transamination of the branched-chain amino-acids (Ichihara et al., 1972) . During a metabolic crisis there were raised levels of at least two of the three fatty acids produced by oxidative decarboxylation of the branched-chain o-keto acids, a finding which supports the in vitro results. The available evidence therefore suggests that our knowledge of the metabolism of the branched-chain amino-acids may be incomplete.
Activities were estimated using a method similar to that of Dancis et al. (1972) using L-leucine and t-isoleucine uniformly labelled with HoC and measuring !teo:;: released.
The cultured cells were obtained using established methods (Sutherland and Bain, 1973) and harvested after trypsinisation. All material was assayed immediately after it had been obtained in view of the marked instability of activity on storage. Leucocytes evidence of reduction of activity in the affected child. were separated from fresh heparinised venous blood Moreover there was no marked loss of activity on by dextran sedimentation (Lehrer, 1971) . Contarni-serial cultures, which is in agreement with results of nating erythrocytes in the pellet were removed by Elsas et al. (1974) . 146 Ratios were obtained by the method of Winter and Christensen (1964) using alanine as the reference compound, which was not absorbed. defect, other possible sites involving all three branched-chain amino-acids were investigated. Damage to plasma membranes could have occurred during trypsinisation of the cultured cells or during leucocyte preparation. It seemed that defects in mitochondrial membrane transport were unlikely since "whole cell" preparations were used in enzyme assay. However, the results in Table 2 show that the radioactivity in extracellular water DL-Ieucine L-
t-Ieucinc phenylalanine
Uptake radioactivity in cell water ratio = ---------
Source of Incubation erythrocytes temperature
"C transport of L-Ieucine, DL-Ieucine, and L-phenylalanine into erythrocytes was similar to controls and to the previous results of Winter and Christensen (1964) . The finding "in crises" of increased concentrations of the fatty acid products of oxidative decarboxylation suggested that there was some overall stimulation and overloading of mitochondrial metabolism during these episodes. Such a defect might arise from a deficiency of branched-chain amino-acid transaminases in the cytosol by a mechanism similar to that shown in the Figure and proposed in hepatic cytosol tyrosine transaminase deficiency (Fellman et al., 1969; Kennaway and Buist, 1971; Kennaway et al., 1972) . Radiochemical assay of branched-chain amino-acid transamination in the plasma and erythrocytes of the affected child was similar to that in controls and thus excludes defective functioning in the cytosol of the "specific" branched-ehain aminoacid transaminases described by Ichihara et al. (1972) .
There remains the possibility that the defect is confined to only some of the metabolically active tissues and yet is not apparent in leucocytes, C 11tured fibroblasts, or amnion cells. Since considerable "branched-chain keto acid decarboxylase" activity has been found in liver and kidney, but not in muscle (Dancis et al., 1961) , the defect might be limited to DISCUSSION Since there was no evidence of the classical enzyme Leucocytes from the affected child's umbilical cord blood and from peripheral blood showed similar rates of decarboxylation of leucine to those in cells from two normal controls determined at the same time. The activities in cpm above blank/h/5 ml blood from the patient's cord blood leucocytes were 22, 36, 14 and from her peripheral blood leucocytes were 14 and 18. Activities from two normal controls' leucocytes were 34 and 18. Leucocytes from children with MSUD showed a marked reduction in activity (Valman eta/., 1973) .
Despite these normal enzyme activities, from the first day after delivery there was a marked and progressive rise in valine, leucine, and isoleucine concentrations despite the precaution of immediate dietary reduction of these amino-acids. The concentrations found in plasma on the second day of life were abnormally high, and alloisoleucine was present. Concentrations in the child's plasma, with normal values on the seventh day of life in parentheses, were 666 (55-438), 945 (21-273), and 305 (32-145) p.mol/I for valine, leucine, and isoleucine respectively when the child was having only about 10 % of the normal intake of these branched-chain amino-acids. There was no response to thiamine in doses up to 30 mg. The father and mother of the affected child had heterozygote responses (Lonsdale et al., 1963) to p.n oral L-Ieucine tolerance test (1.14
The excretion of branched-chain ex-keto acids was raised, as expected in MSUD; the outputs of exketoisovalerate, «-ketoisocaproate, and ex-keto-fJmethyl valerate were 130, 681, and 672 p.mol/24 h respectively. The identities of these compounds were confirmed by thin-layer chromatography of the dinitrophenyl hydrazones. In addition the excretion of isobutyrate, a metabolite of valine by way of exketoisovalerate, and isovalerate, a metabolite of leucine by way of c-ketoisocaproate, were found also to be raised at 87 and 260 p.mol/24 h respectively. The identities and quantitation were checked using two gas chromatography columns, 20% NGA on 60-72 mesh diatomite CQ treated with 2 % phosphoric acid and Poropak QS 100-200. None of these compounds was measurable in normal controls and fell to almost undetectable levels in the affected child when she was "controlled." However, the alloisoleucine concentration in plasma has never been less than 50 p.mol/l. The increase in the metabolic products of the ex-keto acids supports the in vitro findings of normal transport, transamination, and oxidative decarboxylation. kidney and/or liver. Metabolic co-operation between tissues is widespread, and the "integration" of the enzymes necessary for such co-operation is probably subject to genetic control, as in the scheme proposed by Britten and Davidson (1969) . However, we can still only speculate on the site and type of defect in this family.
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